Previous close | 152.06 |
Open | 152.02 |
Bid | 0.00 x 60000 |
Ask | 0.00 x 60000 |
Day's range | 150.82 - 153.84 |
52-week range | 119.00 - 168.80 |
Volume | |
Avg. volume | 210 |
Market cap | 273.203B |
Beta (5Y monthly) | 0.62 |
PE ratio (TTM) | 49.33 |
EPS (TTM) | 3.11 |
Earnings date | 26 Apr 2024 |
Forward dividend & yield | 5.77 (3.76%) |
Ex-dividend date | 15 Jul 2024 |
1y target est | 127.01 |
Key Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to their trading...
AbbVie (NYSE: ABBV) will announce its second-quarter 2024 financial results on Thursday, July 25, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.